Page 2 - Proteome Sciences News Today

/PRNewswire/ -- The global neurological biomarkers market size is estimated to grow by USD 7.82 bn from 2024-2028, according to Technavio. The market is...

Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays. Shares in Proteome fell 12% to 3.18 pence each in London on...

Proteome Sciences plc (LON:PRM – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.20 ($0.04), with a volume of 488064 shares trading hands. The stock had previously closed at GBX 3.49 ($0.04). Proteome […]

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully...

Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

The following stocks are the leading risers and fallers on AIM in London on Thursday. ---------- AIM - WINNERS ---------- Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range...

Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents. Proteome is a London-based protein-focused drug development...

/PRNewswire/ -- The neurological biomarkers market size is expected to grow by USD 6.92 billion from 2022 to 2027. In addition, the momentum of the market will...

RNS Announcements relating to Proteome Sciences . All announcements from sources including RNS,PRN,BZW,NLK,CCN,CIS,HUG,AFX,TNS